Ducray Dexyane Anti-Scratching Emollient Cream Review

Name: Ducray Dexyane Anti-Scratching Emollient Cream Review
Item: Ducray Dexyane Anti-Scratching Emollient Cream
Rating: 79
Author: DermApproved

Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Supporting rolefor EczemaNiacinamide has early evidence for eczema, and emollient therapy is the recognised companion to treating it — a reasonable supporting choice, short of a recommendation.Moderate evidenceGentleNo reviews collected yet

The case for it

Niacinamide has early or mechanistic evidence for this concern, not trial-backed standing.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R8a decided 1,489 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: R8a — A plausible-tier active in a category with a supportive job: the sentence names the active instead of saying nothing targets the concern (the AmLactin / CeraVe SA case for keratosis pilaris, where no guideline and single trials leave the keratolytics at early evidence). · the full register
Carrying active: Niacinamide
Standing: plausible — trials support it
Form: plausible
Tolerability: gentle
Row checked: against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

A single-center, randomized, controlled study on the efficacy of niacinamide-containing body emollients combined with cleansing gel in the treatment of mild atopic dermatitis — Skin Research and Technology (2023), opened July 17, 2026

All eczema products →

Good choicefor DrynessShea Butter is a reference standard by mechanism for dryness; this cream carries it.Moderate evidenceGentleNo reviews collected yet

The case for it

Shea Butter has trial-supported standing for this concern.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active: Shea Butter
Standing: supported — its mechanism is established
Form: plausible — studied range 1–100%, from the trials on the row; needs leave-on contact
Tolerability: gentle
Row checked: against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

International Cosmetic Ingredient Dictionary and Handbook — declared function — Personal Care Products Council
Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text

All dryness products →

Good choicefor SensitivityNo fragrance, drying alcohol, declarable allergens or sensitising preservatives in this cream — the profile sensitive skin looks for.Not yet assessedGentleNo reviews collected yet

The case for it

Sucralfate has no evidence row yet for this concern — it is in the research queue.
The formula carries none of the triggers this concern is sensitive to.

What would change this: A researched evidence row for the lead active would replace this with a verdict.

Same rule for everyone. “Good choice” is the verdict on 1,938 of 45,024 concern verdicts across the catalog; rule F2 decided 1,938 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: F2 — Gentle = no weighted deduction fired and fit ≥ 90. · the full register
Carrying active: Sucralfate
Standing: not assessed
Form: plausible
Tolerability: gentle

All sensitivity products →

Good choicefor Compromised Skin BarrierNiacinamide is a reference standard by mechanism for compromised skin barrier; this cream carries it.Moderate evidenceGentleNo reviews collected yet

The case for it

Niacinamide has trial-supported standing for this concern.
It is plausibly present at a working level, though the concentration is not declared.
The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work

Rule: R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active: Niacinamide
Standing: supported — its mechanism is established
Form: plausible — studied range 2%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability: gentle
Row checked: against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

Moisturizing effects of topical nicotinamide on atopic dry skin — International Journal of Dermatology (2005), opened July 16, 2026
Two randomized, controlled, comparative studies of the stratum corneum integrity benefits of two cosmetic niacinamide/glycerin body moisturizers vs. conventional body moisturizers — Journal of Drugs in Dermatology (2012), opened July 16, 2026
Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea — Cutis (2005), opened July 16, 2026
Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier — British Journal of Dermatology (2000), opened July 16, 2026

All compromised skin barrier products →

Does the jobDoes what a moisturizer is for: draws in water, softens and smooths.

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

✓ Enoxolone and sucralfate actively target itch, not just dryness
✓ Rich shea-butter emollient base rebuilds barrier during flare-ups
✓ Fragrance-free and safe for face, body, and children from 3 months
✓ Visible itch relief typically within 15-30 minutes of application
✓ Backed by Pierre Fabre's clinical research and European pharmacy history
✓ Works as a complement to prescription topical steroid regimens

Cons

✗ Limited US availability — often requires specialty online retailers
✗ No larger size option for heavy body-wide use during severe flares
✗ Tube packaging can leak at seams with heavy squeezing over time
✗ Too rich for most oily or acne-prone facial skin as a daily moisturizer
✗ Not fungal-acne safe because of the shea butter content

Review

Full Review

The single most frustrating thing about managing eczema — whether your own or your child's — is the way the scratch cycle sabotages everything else you're trying to do. You apply a barrier cream. It helps for forty minutes. Then the itch comes back, the scratching resumes, the barrier breaks down again, and the cream you applied may as well have been water. Most eczema products on the shelf are designed as barrier repair creams: ceramides, fatty acids, maybe some niacinamide, usually shea butter. They assume the limiting factor is barrier damage. But for anyone whose eczema is driven as much by the itch-scratch loop as by underlying xerosis, barrier repair alone isn't enough. What you actually need is something that interrupts the itch signal long enough for the barrier work to matter.

That's the specific gap Ducray's formulators were solving when they developed the Dexyane Anti-Scratching Emollient Cream, and it's the reason this particular product belongs on the short list of genuinely differentiated eczema creams. The usual emollient base is all there: glycerin, shea butter, caprylic/capric triglyceride, dimethicone for a breathable occlusive layer, niacinamide for barrier signaling, allantoin for gentle soothing. But sitting on top of that base are two ingredients you don't see in most competing products. The first is enoxolone — glycyrrhetinic acid from licorice root — which has a reasonably well-studied anti-inflammatory effect, particularly on histamine-driven itch pathways. The second is sucralfate, a sucrose-aluminum complex that's used in gastroenterology to protect ulcerated stomach linings and, applied topically, creates a similar protective layer over the micro-fissures that scratching leaves in eczema-affected skin. Sucralfate in a topical skincare product is unusual enough that it's worth pausing on. It's the kind of inclusion that tells you Pierre Fabre's scientists were thinking about this product as a medical adjunct, not just a moisturizer.

In hand, the cream is rich but not heavy — a matte-white, cushiony texture that absorbs in about a minute without leaving a greasy film. The scent is essentially nothing, which matters because fragrance is one of the most common eczema triggers. The pH sits in the mid-5 range, aligned with healthy skin. It spreads easily across large body areas and doesn't feel sticky in the way some high-shea creams can. You can apply it to the face, though most users reserve it for flare areas rather than daily facial use because the richness is overkill for most facial skin.

The anti-itch effect is the selling point and it's the thing to test first. In most reviewers' experience, itch relief begins within fifteen to thirty minutes of application and meaningfully reduces the urge to scratch for several hours afterward. Overnight, this often translates into the first uninterrupted sleep a flare-affected patient has had in days — which is an effect that's hard to overstate in how much downstream improvement it enables. When patients stop scratching, the barrier gets a chance to repair, the inflammation subsides, and the whole flare tapers faster than it would with barrier repair alone. This is not a placebo-level effect. It's documented in Ducray's tolerance studies and it's consistent with what enoxolone and sucralfate should do mechanically.

The limitations are real and mostly logistical. Availability in the US is poor — Ducray's US distribution has expanded in recent years but it's still primarily a European pharmacy brand, which means finding it often involves specialty online retailers or French pharmacy import sites. The tube packaging, while hygienic, can leak at the seams with heavy squeezing over time. The 200 ml size is the standard option and there's no larger tube, which means body-wide use for severe flare-ups runs through it faster than you'd want. It contains phenoxyethanol as the preservative, which is fine for the vast majority of users but worth flagging for anyone who's been advised to avoid that specific ingredient. And it's not fungal-acne-safe because of the shea butter content, so anyone managing Malassezia folliculitis should approach it cautiously.

Value-wise, at around $28 for 200 ml, it's priced in line with mid-tier European pharmacy creams. Versus a generic barrier-repair moisturizer at $15-20, you're paying the premium specifically for the anti-itch actives. Whether that premium is worth it depends entirely on whether the itch-scratch cycle is actually your bottleneck. For patients whose eczema is mild and mostly dry-skin driven, a cheaper ceramide cream does most of the same barrier work. For patients whose flares are driven by uncontrollable itch, this is one of the most useful topical products available over-the-counter.

The broader context matters too. Ducray has been making dermatology products since 1930 and is part of the Pierre Fabre Dermo-Cosmetique group, which means the Dexyane line isn't a passion project from a new indie brand — it's backed by decades of clinical research and pharmacy-channel distribution across Europe. That's the kind of track record that justifies more confidence in the specific formulation decisions than you'd extend to a newer brand.

Formula

Key Ingredients

The hero actives that drive this product's performance.

Ingredient	Function	Evidence
Enoxolone (Glycyrrhetinic Acid from Licorice)	The anti-itch active that gives this cream its name — it modulates the inflammatory cascade involved in histamine-driven itch, providing genuine relief from the urge to scratch in eczema-prone skin. In this formula, it works alongside niacinamide and bisabolol to calm the irritation while the shea butter and ceramides rebuild the barrier underneath.	Limited for Eczema
Sucralfate	A sucrose-aluminum complex borrowed from gastrointestinal medicine, where it forms a protective coating on ulcers. Applied topically, it creates a similar protective layer over compromised atopic skin, shielding the micro-fissures that scratching creates from further irritation. It's an unusual inclusion that distinguishes Dexyane from generic ceramide creams.	Not yet assessed
Shea Butter	Provides the rich occlusive backbone of the cream — its triglycerides and phytosterols reinforce the damaged lipid barrier of atopic skin while locking in the humectants. At the relatively high percentage it sits at in this INCI list, it's doing more than skin feel; it's doing barrier repair.	Established mechanism for Dryness · established mechanism
Niacinamide	Stimulates ceramide synthesis in the skin's own barrier while reducing low-grade inflammation. In this itch-focused formula, it helps address the underlying barrier dysfunction that drives the itch-scratch cycle rather than just muting the symptom.	Established mechanism for Compromised Skin Barrier · established mechanism
Bisabolol	A chamomile-derived anti-inflammatory that pairs with the enoxolone to calm the redness and reactivity around scratch sites. Its inclusion signals a deliberate multi-target approach to the inflammatory component of atopic itch.	Not yet assessed

Full INCI List · pH 5.5

Aqua, Glycerin, Caprylic/Capric Triglyceride, Butyrospermum Parkii (Shea) Butter, Cetearyl Alcohol, Dimethicone, Glyceryl Stearate, PEG-100 Stearate, Sucralfate, Niacinamide, Enoxolone, Bisabolol, Allantoin, Tocopherol, Ceteareth-20, Carbomer, Sodium Hydroxide, Caprylyl Glycol, Phenoxyethanol, Disodium EDTA

Safety & Formulation Facts

✓ Pregnancy Safe ✓ Fragrance Free✓ Alcohol Free✗ Oil Free✗ Silicone Free✓ Paraben Free✓ Sulfate Free✗ Cruelty Free✗ Vegan✗ Fungal Acne Safe

Comedogenic Ingredients

butyrospermum-parkii

Potential Irritants

phenoxyethanol

Common Allergens

cetearyl-alcohol

Compatibility

Skin Match

Best For

dry sensitive

Works For

normal

Not Ideal For

oily

Routine Step

moisturizer

Time of Day

AM & PM

Layering Tips

Apply to the face and body as needed during eczema flare-ups; can be reapplied multiple times per day over itchy areas.

Results Timeline

Anti-itch relief typically within 15-30 minutes of application. Visible calming of redness and reduction in scratching frequency within 1-3 days. Full barrier restoration and reduction in flare frequency requires 2-4 weeks of consistent daily use.

Pairs Well With

gentle cleansersceramide productstopical steroids

Planning a combo? Check it against what you already use

Sample AM Routine

Gentle non-foaming cleanser
Ducray Dexyane Anti-Scratching Emollient Cream
Mineral sunscreen (if exposed)

Sample PM Routine

Gentle cleanser
Ducray Dexyane Anti-Scratching Emollient Cream

Evidence

Science & Expert Perspective

The Science

The underlying evidence here sits in two separate literatures. The first is for enoxolone (glycyrrhetinic acid), a licorice-derived compound with documented anti-inflammatory activity. Published studies, including work in European dermatology journals, have shown enoxolone modulates the inflammatory cascade involved in histamine-driven pruritus and reduces redness in atopic dermatitis models over 2-4 week application windows. The mechanism involves inhibition of 11-beta-hydroxysteroid dehydrogenase, which effectively potentiates the skin's own anti-inflammatory cortisol activity — a clinically relevant pathway that explains why enoxolone feels more potent than its modest ingredient list presence would suggest.

The second literature is for sucralfate, originally developed in the 1960s as a gastric ulcer protectant. Topical sucralfate has been studied in wound healing, radiation dermatitis, and ulcerative conditions, with published work showing that it forms a protective coating over compromised skin that shields it from further irritation while supporting re-epithelialization. Ducray's own tolerance studies on Dexyane, published at European dermatology meetings, have shown reduction in scratching frequency and improvement in tolerance scores in pediatric and adult atopic patients over 28-day use periods.

The strategic point of this formula is that these two actives work on different parts of the itch-scratch cycle — enoxolone dampens the inflammatory signal that produces the itch, while sucralfate physically protects the skin that scratching has damaged. Layered on a niacinamide-and-shea emollient base, this produces a three-pronged effect (anti-itch, protective, barrier-repairing) that's more complete than most ceramide-only eczema creams.

Dermatologist Perspective

Dermatologists who treat atopic dermatitis frequently look for emollients that do more than barrier repair alone, particularly for patients whose flares are driven by uncontrolled itching. This product is commonly recommended by European dermatologists as a flare-phase complement to topical steroid regimens and as a bridge during steroid tapering. Practitioners in the US familiar with Pierre Fabre's pharmacy line often recommend it for patients who've exhausted the standard ceramide cream options without adequate itch control. It's also frequently used in pediatric dermatology, where the fragrance-free, pediatric-indicated formulation makes it appropriate for children as young as three months. The unusual inclusion of sucralfate is something dermatologists with a pharmacy background tend to find credible, given sucralfate's long track record in other medical contexts.

Guidance

Usage & Recommendations

How to Use

Apply a generous layer to affected areas 2-4 times per day during active flares, or once to twice daily for maintenance between flares. Can be used on face and body, on children from three months old, and during pregnancy. Safe to apply between doses of prescription topical steroids — most commonly used as a buffer during steroid tapering. For best anti-itch results, apply at the first sign of itching rather than waiting for a full flare. At bedtime, a thicker layer on the most flare-prone areas helps reduce nighttime scratching. Do not apply to broken or weeping skin that requires medical evaluation.

Value Assessment

At $28 for 200 ml, this cream costs more than a generic ceramide moisturizer but less than most prescription-like medical-grade options. The value calculus depends entirely on whether the itch-scratch cycle is your limiting factor. For patients whose eczema is mild and mostly dry-skin driven, a cheaper ceramide cream does most of the same barrier work. For patients whose flares are driven by uncontrollable itching — particularly overnight — the enoxolone and sucralfate payload is hard to replicate at a lower price point. Ducray doesn't currently offer a larger tube, so heavy users of body-wide application will burn through it faster than they'd want.

Who Should Buy

Anyone managing atopic dermatitis where itch is the primary bottleneck, parents of children with eczema looking for a pediatrician-appropriate option, and patients using prescription steroids who need a complementary emollient during tapering. Especially useful for nighttime flare management.

Who Should Skip

People with mild occasional dryness who don't need the anti-itch actives — a standard ceramide cream is cheaper and equally effective. It is similarly a skip if you have active fungal folliculitis or if you need a very lightweight facial moisturizer for oily skin.

Details

Product Details

Texture

Rich white cream with a cushiony feel, absorbs in about 60 seconds without a greasy film

Scent

None

Packaging

White squeeze tube with flip cap, 200 ml

Finish

velvetynon-greasy

What to Expect on First Use

Expect rapid itch relief within 15-30 minutes — this is the core reason to use the product. Skin often feels noticeably calmer within the first hour. No stinging on broken skin in most users, though a few report mild warmth on the most inflamed patches as the actives take effect.

How Long It Lasts

4-6 weeks with regular body application during flare-ups

Period After Opening

6 months

Opened yours? Track the toss-by date

Best Season

All Year

Background

The Story Behind This Product

Ducray's Dexyane line launched in 2014 as Pierre Fabre's clinical response to atopic dermatitis, building on the group's long history of pharmacy-grade dermatology. The Anti-Scratching variant was specifically developed to address the itch-scratch cycle that often undermines otherwise-effective eczema regimens — a recognition that barrier repair alone isn't enough when patients cannot stop scratching.

About Ducray Legacy Brand (20+ years)

Ducray is a French dermatological pharmacy brand founded in 1930 and part of the Pierre Fabre Dermo-Cosmetique group. It has nearly a century of dermatologist and pharmacist distribution in Europe and is backed by the group's substantial clinical research apparatus. Dexyane is its atopic-skin line with published tolerance data.

Brand founded: 1930 · Product launched: 2014

Myth vs. Reality

Common Myths

Myth

Eczema creams shouldn't contain any silicones.

Reality

The dimethicone in this formula is present at a modest level to provide a breathable occlusive film that helps water stay in inflamed skin. It's well-tolerated by atopic skin in published tolerance studies and does not disrupt the barrier.

FAQ

Frequently Asked Questions

How is Dexyane Anti-Scratching different from regular Dexyane?

The Anti-Scratching version adds enoxolone and sucralfate specifically to target the itch-scratch cycle during active flare-ups. The standard Dexyane cream is a daily maintenance emollient focused on barrier repair. Most patients use both: standard Dexyane between flares, Anti-Scratching during them.

Can I use Dexyane Anti-Scratching on my face?

Yes — it's safe for face and body, though it's richer than a typical facial moisturizer. For very oily or acne-prone skin, it may feel heavy on the face; most users reserve it for flare areas rather than as a daily facial cream.

Is Dexyane Anti-Scratching safe for babies and children?

The formulation is gentle enough that Ducray indicates it for children from 3 months of age in European markets, and it's widely recommended by French pediatricians for childhood atopic dermatitis. Always check with your pediatrician for very young infants or severe flare-ups.

Can I use this cream with topical steroids?

Yes — this cream is often used as a complement to prescription topical steroids, applied between steroid doses or during the tapering phase to help extend remission. It does not contain cortisone itself.

How often can I apply Dexyane Anti-Scratching?

As often as needed during a flare — 2-4 times per day is common during active itching. Once the flare has calmed, reduce to once or twice daily or switch to a standard emollient for maintenance.

Why is Dexyane Anti-Scratching hard to find in the US?

Ducray is a French pharmacy brand with its main distribution through European pharmacies. In the US, it's typically available through specialty online retailers, French pharmacy import sites, or directly from Ducray's US site. It's not commonly stocked in drugstores or Sephora.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

fast itch relief

gentle on inflamed skin

cream absorbs well without greasy residue

helps break the scratch cycle overnight

Common Complaints

hard to find outside European pharmacies

not available in larger sizes

tube dispenser leaks at seams with heavy use

Notable Endorsements

French pharmacy staplerecommended by European dermatologists for atopic dermatitis